Status:

UNKNOWN

Evaluation of Muscle Oxidative Capacity Relationship With Muscular Endurance, Fatigue (Multiple Sclerosis).

Lead Sponsor:

University Hospital, Clermont-Ferrand

Conditions:

Multiple Sclerosis

Eligibility:

All Genders

18-80 years

Brief Summary

Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system. It is characterized by different progressive forms with periods of flare-ups interspersed with phases of remiss...

Detailed Description

Following an arterial occlusion, the rate of decay of the NIRS signal is only dependent on local O2 consumption. Following an exercise increasing the oxygen consumption of the muscle (isometric contra...

Eligibility Criteria

Inclusion

  • Patients with Multiple Sclerosis (MS) with a diagnosis established by MRI.
  • Patients with a Kurtzke Expanded Disability Status Scale (EDSS) score \< 5.
  • Body mass index (BMI) \< 30 Kg/m².
  • Thickness of subcutaneous adipose tissue at the calf ≤ 20 mm.
  • MS patients without neurological signs of flare-up since 1 month.
  • MS patients who have not had any treatment modification during the last 2 months.
  • Subjects affiliated to French health care system (for France).
  • Volunteers who have given their written consent.

Exclusion

  • Patients suffering from progressive psychiatric pathologies (active psychosis, , etc.) or the presence of another serious unstabilized pathology (decompensated heart failure, progressive terminal cancer, etc.).
  • People with poorly controlled or unstable cardiovascular disease.
  • Major osteoarticular or neurological problems completely preventing the proper performance of the various tests.
  • Persons under guardianship, curatorship, deprived of liberty or safeguarding justice.
  • Pregnant or lactating women.

Key Trial Info

Start Date :

January 14 2024

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

June 1 2025

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT06083194

Start Date

January 14 2024

End Date

June 1 2025

Last Update

January 17 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

CHU clermont-ferrand

Clermont-Ferrand, France, 63000